Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16240
Title: Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery
Austin Authors: Le Roux, Pierre-Yves;Leong, Tracy L ;Barnett, Stephen A ;Hicks, Rodney J;Callahan, Jason;Eu, Peter;Manser, Renee;Hofman, Michael S
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Nuclear Medicine department, Brest University Hospital, Brest, France
Service de médecine nucléaire, CHRU de Brest, Brest Cedex, France
The University of Melbourne, Parkville, Victoria, Australia
Department of Surgery, Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Department of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia
Department of Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
Issue Date: 20-Aug-2016
metadata.dc.date: 2016-08-20
Publication information: Cancer Imaging 2016; 16(1): 24
Abstract: BACKGROUND: Pre-operative evaluation of lung cancer patients relies on calculation of predicted post-operative (PPO) lung function based on split lung function testing. Pulmonary perfusion (Q) PET/CT can now be performed by substituting Technetium-99 m labeling of macroaggregated albumin (MAA) with Gallium-68. This study compares Q PET/CT with current recommended methods of pre-operative lung function assessment. METHODS: Twenty-two patients planned for curative surgical resection (mean FEV1 77 %, SD 21 %; mean DLCO 66 %, SD 17 % predicted) underwent pre-operative Q PET/CT. Sixteen patients also underwent conventional lung scintigraphy. Lobar and lung split PPO lung function were calculated using Q PET/CT and current recommended methods, i.e. calculation based on anatomical segments for lobar function, and conventional perfusion scan for pneumonectomy. Bland-Altman statistics were used to calculate agreement between methods for PPO FEV1 and PPO DLCO. RESULTS: While mean split lobar functions were comparable, there was variation on an individual level between Q PET/CT and the anatomical method, with absolute difference over 5 % and 10 % in 37 % and 11 % of patients, respectively. For lobectomy the mean difference in PPO FEV1 was-1.2, but limits of agreement were-10 to 8.1 %. For DLCO, values were-1.1 % and-9.7 to 7.5 %, respectively. For pneumonectomy, PPO FEV1 values were-0.4 and-5.9 to 5.1 %. For DLCO, values were 0.3 % and-5.1 to 4.6 %. CONCLUSIONS: While anatomic estimation provides "fixed" results, split lobar functions computed with Q PET/CT vary widely, reflecting the intra and inter-individual variability of regional lung function. Further studies to assess the role of Q PET/CT in predicting peri-operative risk in lung cancer patients planned for lobectomy are warranted.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16240
DOI: 10.1186/s40644-016-0081-5
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27544383
Type: Journal Article
Subjects: Gallium-68
Lung cancer
PET/CT
Perfusion
Surgery
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.